Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $729000.0.

  • Utah Medical Products' Change in Accured Expenses rose 20768.09% to $729000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$846000.0, marking a year-over-year increase of 5271.1%. This contributed to the annual value of -$1.5 million for FY2024, which is 576.65% down from last year.
  • According to the latest figures from Q3 2025, Utah Medical Products' Change in Accured Expenses is $729000.0, which was up 20768.09% from -$1.9 million recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Change in Accured Expenses registered a high of $1.4 million during Q3 2022, and its lowest value of -$1.9 million during Q2 2025.
  • For the 5-year period, Utah Medical Products' Change in Accured Expenses averaged around -$145421.1, with its median value being -$98000.0 (2021).
  • As far as peak fluctuations go, Utah Medical Products' Change in Accured Expenses crashed by 153636.36% in 2021, and later skyrocketed by 20768.09% in 2025.
  • Over the past 5 years, Utah Medical Products' Change in Accured Expenses (Quarter) stood at -$98000.0 in 2021, then tumbled by 739.8% to -$823000.0 in 2022, then soared by 60.02% to -$329000.0 in 2023, then skyrocketed by 86.63% to -$44000.0 in 2024, then soared by 1756.82% to $729000.0 in 2025.
  • Its last three reported values are $729000.0 in Q3 2025, -$1.9 million for Q2 2025, and $360000.0 during Q1 2025.